Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eyenovia Granted US Patent ‘Spray ejector device and methods of use’

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6263&f=G&l=50&d=PTXT&p=126&S1=20220329&OS=20220329&RS=20220329
byBill Haddad
March 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6263&f=G&l=50&d=PTXT&p=126&S1=20220329&OS=20220329&RS=20220329

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Privia Health Partner Javara Reports Launch Of Opportunity For Adults 60+ In 3 Cities In Georgia, Maryland And Texas To Participate In A Trial For Investigational Vaccine Aimed At Protection From Respiratory Syncytial Virus

By Benzinga Newsdesk
February 14, 11:04 AM
Adults Age 60 and Older in Georgia, Maryland and Texas Encouraged to Join Clinical Trial for RSV Prevention Vaccine WINSTON-SALEM, N.C., Feb. 14, 2022 /PRNewswire/ -- Javara, a leading Integrated Research

MRNA